RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Envisia Therapeutics today announced that it has named Benjamin Yerxa, PhD as the company’s President, effective immediately. Dr. Yerxa joined Liquidia Technologies in August 2012 and was critical to the company’s formation of Envisia in November 2013 where he has since served in the dual role of Chief Scientific Officer for both companies. Neal Fowler will remain Chief Executive Officer of Liquidia Technologies and serve as a director on the Envis
| < Prev | Next > |
|---|
